Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study. Meng QH, Halfdanarson TR, Bornhorst JA, Jann H, et al. Clin Cancer Res 2024;30:5559-5567.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Meng QH, Halfdanarson TR, Bornhorst JA, Jann H, et al. Circulating Chromogranin A as a Surveillance Biomarker in Patients with Carcinoids-The CASPAR Study. Clin Cancer Res 2024;30:5559-5567.
PMID: 39453770